Utilidad de la evaluación USG Doppler de las arterias uterinas entre las semanas 11 y 13+6 y su aplicación en las calculadoras de riesgo para predecir preeclampsia

Vista sencilla de ítem
dc.contributor.authorOtero Rosales, María Camila
dc.contributor.authorOlarte Marín, Cristhian David
dc.contributor.authorPadilla Serpa, Johan Danilo
dc.contributor.authorMorales Duarte, Paula Andrea
dc.contributor.authorQuintero Roa, Eliana Maribel
dc.date.accessioned2024-08-05T19:36:08Z
dc.date.available2024-08-05T19:36:08Z
dc.date.issued2021-11-12
dc.description.abstractLa preeclampsia es la primera causa de muerte materna directa en Colombia y la segunda a nivel mundial. El desarrollo de estrategias de predicción y prevención puede disminuir las complicaciones y secuelas ocasionadas por dicha enfermedad. El Doppler de arterias uterinas entre las semanas 11 y 13+6 como prueba independiente o en combinación con factores maternos o pruebas bioquímicas permite tasas de detección de preeclampsia temprana ≥ 90% a partir de la implementación de distintos cribados. La validez de dicha prueba diagnóstica presenta una sensibilidad del 47.8% y especificidad del 92.1% para la detección de preeclampsia temprana; con una sensibilidad del 26.4% y especificidad del 93.4% para predecir preeclampsia en cualquier etapa. División de los temas tratados. En esta revisión de tema se aborda la utilidad de esta medición, se habla de la realización de la técnica en cuestión y, por último, se revisan las herramientas estandarizadas que están disponibles en la actualidad junto con su accesibilidad y precisión. Conclusiones. La evidencia empírica que respalda la validez de las herramientas disponibles hoy en día para el tamizaje de preeclampsia a través de la evaluación por ultrasonografía Doppler de las arterias uterinas es significativa. Al ser Colombia un país que presenta una prevalencia alta de preeclampsia, conocer la utilidad de esta medición favorece una vigilancia temprana y oportuna, lo que disminuye los posibles desenlaces desfavorables para las maternas.spa
dc.description.abstractenglishPreeclampsia is the primary cause of direct maternal death in Colombia and the second globally. The development of prediction and prevention strategies can reduce complications and consequences caused by this disease. The uterine arteries Doppler between weeks 11 and 13+6 as an independent test or in combination with maternal factors or biochemical tests allows for early detection rates for preeclampsia of ≥90% from the implementation of different sieving. The validity of this diagnostic test has a sensitivity of 47.8% and specificity of 92.1% for the early detection of preeclampsia; with a sensitivity of 26.4% and specificity of 93.4% to predict preeclampsia at any stage. Division of Covered Topics. This topic review covers the usefulness of this measurement. It discusses the performance of the technique in question and, lastly, the standardized tools currently available are reviewed together with the accessibility and accuracy. Conclusions. The empirical evidence that supports the validity of the tools available today for the screening of preeclampsia via Doppler ultrasound evaluation of the uterine arteries is significant. As Colombia is a country with a high prevalence of preeclampsia, knowing the usefulness of this measurement favors early and timely surveillance, which reduces possible unfavorable outcomes for mothers.eng
dc.description.abstractotherA pré-eclâmpsia é a principal causa de morte materna direta na Colômbia e a segunda no mundo. O desenvolvimento de estratégias de predição e prevenção pode reduzir as complicações e sequelas causadas pela doença. O Doppler da artéria uterina entre as semanas 11 e 13+6 como um teste independente ou em combinação com fatores maternos ou testes bioquímicos permite taxas de detecção de pré-eclâmpsia precoce≥90% a partir da implementação de diferentes exames. A validade desse teste diagnóstico tem sensibilidade de 47,8% e especificidade de 92,1% para a detecção de pré-eclâmpsia precoce; com uma sensibilidade de 26,4% e especificidade de 93,4% para prever pré-eclâmpsia em qualquer fase. Divisão dos tópicos abordados. Esta revisão de tópicos aborda a utilidade desta medição, discute a realização da técnica em questão e, por fim, são revisadas as ferramentas padronizadas que estão disponíveis atualmente, juntamente com sua acessibilidade e precisão. Conclusões. A evidência empírica que apoia a validade das ferramentas disponíveis atualmente para rastreamento de pré-eclâmpsia por meio da avaliação de ultrassom Doppler das artérias uterinas é significativa. Como a Colômbia é um país com alta prevalência de pré-eclâmpsia, conhecer a utilidade dessa medição favorece a vigilância precoce e oportuna, o que reduz possíveis resultados desfavoráveis para mulheres maternas.por
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.29375/01237047.3953
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issni-ISSN 0123-7047spa
dc.identifier.issne-ISSN 2382-4603spa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/25926
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/3953/3546spa
dc.relation.referencesLakshmy S, Ziyaulla T, Rose N. The need for implementation of first trimester screening for preeclampsia and fetal growth restriction in low resource settings. J Matern-Fetal Neo M [Internet]. 2020;34(24):4082-9. doi: https://doi.org/10.1080/147 67058.2019.1704246
dc.relation.referencesInstituto Nacional de Salud; Boletín Epidemiológico Semanal [Internet]. Semana Epidemiológica 23.. 2019. Recuperado a partir de: https://www.ins.gov.co/ buscador-eventos/BoletinEpidemiologico/2019%20 Bolet%C3%ADn%20epidemiol%C3%B3gico%20 semana%2023.pdf
dc.relation.referencesEl-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol [Internet]. 2017;56(5):593- 8. doi: https://doi.org/10.1016/j.tjog.2017.08.004
dc.relation.referencesSotiriadis A, Hernandez-Andrade E, da Silva Costa F, Ghi T, Glanc P, Khalil A, et al. ISUOG Practice Guidelines: Role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol. [Internet]. 2019;53(1):7-22. doi: https://doi. org/10.1002/uog.20105
dc.relation.referencesCampbell S, Griffin DR, Pearce JM, Diaz-Recasens J, Cohen-Overbeek TE, Willson K, et al. New doppler technique for assessing uteroplacental blood flow. Lancet [Internet]. 1983;321(8326):675-677. doi: https://doi.org/10.1016/s0140-6736(83)91970-0
dc.relation.referencesAcolet D, Springett A, Golightly S. Perinatal Mortality 2006 [Internet]. Confidential Enquiry into Maternal and Child Health; 2008. Recuperado a partir de: https://www.oaa-anaes.ac.uk/assets/_managed/editor/ File/Reports/2006_Perinatal_mortality.pdf
dc.relation.referencesFarré MT, Borrell A, Ravenau W, Azulay M, Cararach V, Fortuny A. Estudio Doppler de las arterias uterinas: predicción de complicaciones perinatales. Prog Obstet Ginecol [Internet]. 2001;44(12):537-43. doi: https:// doi.org/10.1016/S0304-5013(01)75714-7
dc.relation.referencesPapageorghiou A, Yu CKH, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre- eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18(5):441-9. doi: https://doi.org/10.1046/j.0960-7692.2001.00572.x
dc.relation.referencesMartin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol [Internet]. 2001;18(6):583-6. doi: https://doi.org/10.1046/ j.0960-7692.2001.00594.x
dc.relation.referencesVelauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: A meta-analysis involving 55974 women. Ultrasound Obstet Gynecol [Internet]. 2014;43(5): 500-7. doi: https://doi.org/10.1002/uog.13275
dc.relation.referencesvon Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin F, Côté AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet [Internet]. 2011;377(9761):219-27. doi: https://doi.org/10.1016/ S0140-6736(10)61351-7
dc.relation.referencesChaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol [Internet]. 2014;10:466-80. doi: https://doi.org/10.1038/ nrneph.2014.102
dc.relation.referencesOrabona R, Donzelli C, Falchetti M, Santoro A, Valcamonico A, Frusca T. Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre- eclampsia. Ultrasound Obstet Gynecol [Internet]. 2016;47(5):580-5. doi: https://doi.org/10.1002/ uog.15799
dc.relation.referencesBujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of Preeclampsia and Intrauterine Growth Restriction with Aspirin Started in Early Pregnancy: A Meta-Analysis. Obstet Gynecol [Internet]. 2010;116(2p1):402-14. doi: https://doi. org/10.1097/aog.0b013e3181e9322a
dc.relation.referencesDugoff L, Lynch AM, Cioffi-Ragan D, Hobbins JC, Schultz LK, Malone FD, et al. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet [Internet]. 2005;193(3):1208-12. doi: https://doi.org/10.1016/j. ajog.2005.06.05
dc.relation.referencesPlasencia W, Barber M, Álvarez E, Segura J, Valle L, Garcia-Hernandez J. Comparative Study of Transabdominal and Transvaginal Uterine Artery Doppler Pulsatility Indices at 11-13 + 6 Weeks. Hypertens Pregnancy. 2011;30(4):414-20. doi: https:// doi.org/10.3109/10641955.2010.506232
dc.relation.referencesCortés-Yepes H. Doppler de arterias uterinas en el primer trimestre del embarazo para la detección de los trastornos hipertensivos asociados con el embarazo: estudio de cohorte. Bogotá (Colombia) 2007-2008. Rev Colomb Obstet Ginecol. [Internet]. 2009;60(4):328-33. doi: https://doi.org/10.18597/ rcog.315
dc.relation.referencesKhalil A, Nicolaides KH. How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynecol [Internet]. 2013;42:478-9. doi: https://doi. org/10.1002/uog.12366
dc.relation.referencesWitlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet [Internet]. 2000;182(3):607- 11. doi: https://doi.org/10.1067/mob.2000.104224
dc.relation.referencesDemers ME, Dubé S, Bourdages M, Gasse C, Boutin A, Girard M et al. Comparative Study of Abdominal Versus Transvaginal Ultrasound for Uterine Artery Doppler Velocimetry at 11 to 13 Weeks. J Ultrasound Med [Internet]. 2018;37(7):1771-6. doi: https://doi. org/10.1002/jum.14530
dc.relation.referencesTayyar A, Guerra L, Wright A, Wright D, Nicolaides KH. Uterine artery pulsatility index in the three trimesters of pregnancy: Effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol [Internet]. 2015;45(6):689-97. doi: https:// doi.org/10.1002/uog.14789
dc.relation.referencesRivas M, González X, Guevara H. Valores de referencia del índice de pulsatilidad de la arteria uterina durante el embarazo. Rev Obstet Ginecol Venez [Internet]. 2016;76(3):225-31. Recuperado a partir de: http://ve.scielo.org/scielo.php?script=sci_ arttext&pid=S0048-77322016000400002&lng=es
dc.relation.referencesFerreira AEGMT, Mauad Filho F, Abreu PSG, Mauad FM, Araujo Júnior E, Martins WP. Reproducibility of first- and second-trimester uterine artery pulsatility index measured by transvaginal and transabdominal ultrasound. Ultrasound Obstet Gynecol [Internet]. 2015;46(5):546-52. doi: https://doi.org/10.1002/ uog.14762
dc.relation.referencesPeixoto A, Rodrigues Da Cunha Caldas T, Tonni G, Almeida Morelli P, Santos L, Martins W, et al. Reference range for uterine artery Doppler pulsatility index using transvaginal ultrasound at 20-24w6d of gestation in a low-risk Brazilian population. J Turk Ger Gynecol Assoc. 2016;17:16-20. doi: https://doi. org/10.5152/jtgga.2016.16192
dc.relation.referencesGómez O, Martínez JM, Figueras F, Del Río M, Borobio V, Puerto B, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol [Internet]. 2005;26(5):490-4. doi: https://doi. org/10.1002/uog.1976
dc.relation.referencesPoon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet [Internet]. 2019;145(S1):1-33. doi: https://doi. org/10.1002/ijgo.12802
dc.relation.referencesO'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol [Internet]. 2016;214(1):103.e1-12. doi: https://doi.org/10.1016/j.ajog.2015.08.034
dc.relation.referencesO'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing- risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol [Internet]. 2017;49(6):751-755. doi: https://doi.org/10.1002/ uog.17399
dc.relation.referencesO'Gorman N, Wright D, Poon L, Rolnik D, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: Comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol [Internet]. 2017;49(6):756-60. doi: https://doi.org/10.1002/uog.17455
dc.relation.referencesACOG. First-Trimester Risk Assessment for Early- Onset Preeclampsia. Committee opinion No. 638. Obstet Gynecol. 2015;126:e25-7. doi: https://doi. org/10.1097/aog.0000000000001049
dc.relation.referencesNational Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 Aug. (NICE Clinical Guidelines, No. 107.) Recuperado a partir de: https://www.ncbi.nlm.nih.gov/books/NBK62652/
dc.relation.referencesAkolekar R, Syngelaki A, Poon L, Wright D, Nicolaides K. Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers. Fetal Diagn Ther. 2013;33(1):8- 15. doi: https://doi.org/10.1159/000341264
dc.relation.referencesRolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, et al. ASPRE trial: Performance of screening for preterm pre- eclampsia. Ultrasound Obstet Gynecol [Internet]. 2017;50(4):492-5. doi: https://doi.org/10.1002/ uog.18816
dc.relation.referencesSkråstad R, Hov G, Blaas H, Romundstad P, Salvesen K. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: Prospective evaluation of two algorithms. BJOG [Internet]. 2015;122(13):1781-8. doi: https://doi. org/10.1111/1471-0528.13194
dc.relation.referencesLakovschek IC, Ulrich D, Jauk S, Csapo B, Kolovetsiou-Kreiner V, Mayer-Pickel K, et al. Risk assessment for preterm preeclampsia in first trimester: Comparison of three calculation algorithms. Eur J Obstet Gynecol [Internet]. 2018;231:241-7. doi: https://doi.org/10.1016/j.ejogrb.2018.11.006
dc.relation.referencesDuley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol [Internet]. 2009;33(3):130-7. doi: https://doi.org/10.1053/j. semperi.2009.02.010
dc.relation.referencesO'Gorman N, Nicolaides K, Poon L. The Use of Ultrasound and other Markers for Early Detection of Preeclampsia. Womens Health. 2016;12(2):199-207. doi: https://doi.org/10.2217/whe.15.95
dc.relation.referencesWright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation. Am J Obstet Gynecol [Internet]. 2019;220(2):197.e1-11. doi: https://doi.org/10.1016/j.ajog.2018.10.092
dc.relation.referencesTan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for pre- eclampsia by maternal factors and biomarkers at 11-13weeks' gestation. Ultrasound Obstet Gynecol [Internet]. 2018;52(2):186-195. doi: https://doi. org/10.1002/uog.19112
dc.relation.referencesRidding G, Schluter PJ, Hyett JA, McLennan AC. Uterine Artery Pulsatility Index Assessment at 11-13 Weeks' Gestation. Fetal Diagn Ther [Internet]. 2014;36:299-304. doi: https://doi. org/10.1159/000361021
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/issue/view/277spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.sourceVol. 24 Núm. 3 (2021): diciembre 2021 - marzo 2022: COVID-19, Embolia y Trombosis, Neoplasias; 375-383spa
dc.subjectPreeclampsiaspa
dc.subjectUltrasonografíaspa
dc.subjectUltrasonografía Prenatalspa
dc.subjectArteria Uterinaspa
dc.subjectAtención Prenatalspa
dc.subjectDiagnóstico Prenatalspa
dc.subjectRetardo del Crecimiento Fetalspa
dc.subjectPruebas Prenatales no Invasivasspa
dc.subject.keywordsMedical scienceseng
dc.subject.keywordsLife scienceseng
dc.subject.keywordsPre-Eclampsiaeng
dc.subject.keywordsUltrasonographyeng
dc.subject.keywordsUltrasonography Prenataleng
dc.subject.keywordsUterine Arteryeng
dc.subject.keywordsPrenatal Careeng
dc.subject.keywordsPrenatal Diagnosiseng
dc.subject.keywordsFetal Growth Retardationeng
dc.subject.keywordsNoninvasive Prenatal Testingeng
dc.subject.keywordsHealth scienceseng
dc.subject.keywordsCiências médicaspor
dc.subject.keywordsCiências da vidapor
dc.subject.keywordsCiências da saúdepor
dc.subject.keywordsPré-Eclâmpsiapor
dc.subject.keywordsUltrassonografiapor
dc.subject.keywordsUltrassonografia Pré-Natalpor
dc.subject.keywordsArtéria Uterinapor
dc.subject.keywordsCuidado Pré-Natalpor
dc.subject.keywordsDiagnóstico Pré-Natalpor
dc.subject.keywordsRetardo do Crescimento Fetalpor
dc.subject.keywordsTeste Pré-Natal não Invasivopor
dc.subject.lembCiencias médicasspa
dc.subject.lembCiencias de la vidaspa
dc.subject.proposalCiencias de la saludspa
dc.titleUtilidad de la evaluación USG Doppler de las arterias uterinas entre las semanas 11 y 13+6 y su aplicación en las calculadoras de riesgo para predecir preeclampsiaspa
dc.title.translatedUsefulness of the USG Doppler evaluation of the uterine arteries between weeks 11 and 13+6 and its application in risk calculators to predict preeclampsiaeng
dc.title.translatedUtilidade da avaliação USG Doppler das artérias uterinas entre as semanas 11 e 13+6 e sua aplicação em calculadoras de risco para prever pré-eclâmpsiapor
dc.typeArticleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Artículo.pdf
Tamaño:
471.95 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
183 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Revista MedUNAB